Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Efficacy and Safety of MRI and CT Guided VX2 Hepatic Para-vascular Tumor Model in Rabbits

Author(s): Xu Feng, Sushant K. Das, Gui-Ling Feng, Yan Liu, Ying Liu, Bing Li and Yong Du*

Volume 19, Issue 11, 2023

Published on: 19 October, 2022

Article ID: e290922209275 Pages: 6

DOI: 10.2174/1573405618666220929094804

Price: $65

Abstract

Objective: To compare the efficacy and safety of 1.5 T MRI and CT-guided VX2 hepatic para-vascular tumor model in rabbits.

Materials and Methods: Sixty New Zealand white rabbits were randomly and equally divided into MRI-guided group (n=30) and CT-guided group (n=30). Rabbit VX2 tumor fragments were implanted beside the rabbit hepatic great vessels under MRI and CT guidance in the MRI and CT group to evaluate the success rate of tumor model establishment, puncture needle display and tip peripheral vascular situation, operation time and safety.

Results: In the MRI-guided group, 29 rabbits (29/30, 96.7%) had a successful establishment of liver tumor model, and 1 rabbit had needle metastasis. In the CT-guided group, 24 rabbits (24/30, 80%) had a successful establishment of liver tumor model, while 2 rabbits had needle metastasis, 3 rabbits had metastases in other parts of the liver, and 1 had an unknown cause of death. The differences in tumor model establishment success rate between the two groups were statistically significant (χ2 = 4.043, P < 0.05). The fold number of artifacts at T1WI was 7.26±0.38 for the 20 G coaxial puncture needle in the MRI-guided group and 2.51±0.57 for the 20 G coaxial puncture needle in the CT-guided group, and the difference was statistically significant (t=36.76, P < 0.001), but star-shaped hypodense artifacts would appear around the needle tip. The operation time was longer in the MRI-guided group than in the CT-guided group (13.32±2.45 minutes in the MRI-guided group vs. 8.42±1.46 minutes in the CTguided group; t=9.252, P < 0.001). A small number of ascites occurred in 2 patients (2/30, 6.67%) in the CT-guided group; no serious complications such as liver abscess, jaundice or diaphragmatic perforation were observed in both groups.

Conclusion: Compared with CT, MRI-guided hepatic para-vascular tumor implantation in rabbits might be a more effective modeling method. Although the needle tip pseudopacity of the puncture needle is large and the operation time is long, the incidence of complications is low.

Keywords: MRI, CT, hepatic, para-vascular, efficacy, safety.

Graphical Abstract

[1]
Galle PR, Forner A, Llovet JM, et al. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69(1): 182-236.
[http://dx.doi.org/10.1016/j.jhep.2018.03.019] [PMID: 29628281]
[2]
Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases. Hepatology 2018; 68(2): 723-50.
[http://dx.doi.org/10.1002/hep.29913] [PMID: 29624699]
[3]
Ahmed M, Solbiati L, Brace CL, et al. Image guided tumor ablation: Standardization of terminology and reporting criteria - A 10-year update. Radiology 2014; 273(1): 241-60.
[http://dx.doi.org/10.1148/radiol.14132958] [PMID: 24927329]
[4]
Qiao W, Yu Y, Huang Y, Gao W, Liu Z. Impact of focused ultrasound on the ethanol ablation of VX2 liver tumours in rabbits. Eur Radiol 2020; 30(11): 5862-70.
[http://dx.doi.org/10.1007/s00330-020-06941-3] [PMID: 32533238]
[5]
Yi H, Cai B, Ai X, Li K, Zhang W. Establishment of rabbit liver VX2 tumor model using percutaneous puncture inoculation of tumor fragment guided and evaluated by ultrasonography. Curr Med Sci 2019; 39(5): 820-4.
[http://dx.doi.org/10.1007/s11596-019-2111-6] [PMID: 31612402]
[6]
Chen L, Liu Z, Bi Q, Zhao J, Liang Q, Tang Q. Ultrasound-guided percutaneous ethanol-paclitaxel combined therapy for rabbit VX2 liver tumors. J Hepatocell Carcinoma 2021; 8: 263-70.
[http://dx.doi.org/10.2147/JHC.S301083] [PMID: 33907696]
[7]
Zhang W, Lowerison MR, Dong Z, Miller RJ, Keller KA, Song P. Super resolution ultrasound localization microscopy on a rabbit liver VX2 tumor model: An initial feasibility study. Ultrasound Med Biol 2021; 47(8): 2416-29.
[http://dx.doi.org/10.1016/j.ultrasmedbio.2021.04.012] [PMID: 34045095]
[8]
Lu C, Hui J, Xia S, et al. Application values of 64-row computed tomographic angiography in diagnosing liver VX2 tumor in rabbits. Zhonghua Yi Xue Za Zhi 2015; 95(7): 541-3.
[PMID: 25916934]
[9]
Wang G, Gao Q, Wang Z, Lu X, Yu S, Jin Z. Reduction of microwave ablation needle related metallic artifacts using virtual monoenergetic images from dual-layer detector spectral CT in a rabbit model with VX2 tumor. Sci Rep 2021; 11(1): 9295.
[http://dx.doi.org/10.1038/s41598-021-88853-w] [PMID: 33927327]
[10]
van Breugel JMM, Geschwind JF, Mirpour S, et al. Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model. Theranostics 2019; 9(13): 3674-86.
[http://dx.doi.org/10.7150/thno.32943] [PMID: 31281506]
[11]
Wan RJ, Lin ZY, Li YM, et al. Establishing the rabbit model bearing VX2 tumor near blood vessel in liver under the guidance of MRI. J Med Imaging 2014; 24(5): 865-7.
[12]
Liao R, Zhang D, Li X, et al. A preliminary study on the diagnostic efficacy of proton magnetic resonance spectroscopy at 3.0T in rabbit with VX2 liver tumor. Technol Cancer Res Treat 2021; 20:: 15330338211036852..
[http://dx.doi.org/10.1177/15330338211036852] [PMID: 34372732]
[13]
Virmani S, Harris KR, Szolc-Kowalska B, et al. Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol 2008; 19(6): 931-6.
[http://dx.doi.org/10.1016/j.jvir.2008.02.019] [PMID: 18503910]
[14]
Sun JH, Zhang YL, Nie CH, et al. Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features. Exp Ther Med 2012; 3(3): 386-90.
[http://dx.doi.org/10.3892/etm.2011.435] [PMID: 22969900]
[15]
Weiss J, Hoffmann R, Clasen S. MR-guided liver interventions. Top Magn Reson Imaging 2018; 27(3): 163-70.
[http://dx.doi.org/10.1097/RMR.0000000000000146] [PMID: 29870468]
[16]
Khabbaz RC, Huang YH, Smith AA, Garcia KD, Lokken RP, Gaba RC. Development and angiographic use of the rabbit VX2 model for liver cancer. J Vis Exp 2019; (143): e58600..
[http://dx.doi.org/10.3791/58600] [PMID: 30663668]
[17]
Meloni M, Galimberti S, Dietrich C, et al. Microwave ablation of hepatic tumors with a third generation system: loco regional efficacy in a prospective cohort study with intermediate term follow-up. Z Gastroenterol 2016; 54(6): 541-7.
[http://dx.doi.org/10.1055/s-0042-100627] [PMID: 27284928]
[18]
Song H, Ding H, Zhu C. CT-guided percutaneous microwave ablation of sclerosing hepatic carcinoma. Can J Gastroenterol Hepatol 2020; 2020: 1-8.
[http://dx.doi.org/10.1155/2020/8881978] [PMID: 32733821]
[19]
Hoffmann R, Rempp H, Eibofner F, et al. In vitro artefact assessment of a new MR-compatible microwave antenna and a standard MR-compatible radiofrequency ablation electrode for tumour ablation. Eur Radiol 2016; 26(3): 771-9.
[http://dx.doi.org/10.1007/s00330-015-3891-0] [PMID: 26134999]
[20]
Van Dams R, Wu TC, Kishan AU, et al. Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial. Radiother Oncol 2021; 170: 14-20.
[PMID: 34107296]
[21]
Patel N, King AJ, Breen DJ. Imaging appearances at follow-up after image-guided solid-organ abdominal tumour ablation. Clin Radiol 2017; 72(8): 680-90.
[http://dx.doi.org/10.1016/j.crad.2017.01.014] [PMID: 28237299]
[22]
Boldrini L, Corradini S, Gani C, et al. MR-guided radiotherapy for liver malignancies. Front Oncol 2021; 11: 616027..
[http://dx.doi.org/10.3389/fonc.2021.616027] [PMID: 33869001]
[23]
Shin SW, Ahn KS, Kim SW, Kim TS, Kim YH, Kang KJ. Liver resection versus local ablation therapies for hepatocellular carcinoma within the milan criteria. Ann Surg 2021; 273(4): 656-66.
[http://dx.doi.org/10.1097/SLA.0000000000004350] [PMID: 33074898]
[24]
Li Z, Wang C, Si G, et al. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance? BMC Cancer 2021; 21(1): 366.
[http://dx.doi.org/10.1186/s12885-021-08099-7] [PMID: 33827464]
[25]
Cha DI, Lee MW, Kang TW, et al. Comparison between CT and MR images as more favorable reference data sets for fusion imaging-guided radiofrequency ablation or biopsy of hepatic lesions: A prospective study with focus on patient’s respiration. Cardiovasc Intervent Radiol 2017; 40(10): 1567-75.
[http://dx.doi.org/10.1007/s00270-017-1666-5] [PMID: 28462444]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy